Overview
Ascertain combines healthcare and technology to create AI-powered healthcare ventures. It partners with health systems, most notably Northwell Health, and Aegis Ventures to build and launch AI-enabled companies at scale. The company uses its platform and interdisciplinary team of clinicians, engineers, and business leaders to identify operational opportunities, assemble capable operators, and bring AI tools to healthcare settings. Its products focus on reducing administrative work for clinicians and improving patient care, enabling health systems to serve their communities more effectively. Revenue comes from creating and launching AI-driven healthcare companies that operate on Ascertain’s platform, with the aim of transforming medicine and expanding equitable access to care.
Work here?Claim your company
Simplify's take
What believers are saying
- April 2025 Series A and 2026 Series B show investor conviction in Ascertain.
- October 2026 hiring for sales, product, and engineers signals expansion beyond Northwell pilots.
- Deerfield's November 2026 AWS partnership strengthens deployment capacity across portfolio companies.
What critics are saying
- Waystar and Availity already own payer workflows, compressing Ascertain's differentiation by 2027.
- Ascertain's AWS-dependent agent stack faces platform lock-in if payer integrations break.
- If health systems buy point solutions instead, Ascertain's launch-platform thesis dies and revenue stalls.
What makes Ascertain unique
- Ascertain unifies prior authorization, referrals, eligibility, and care coordination across existing systems.
- Northwell pilot cut clicks 80% and submission time 67% by October 2026.
- The Oncology Institute deployment reached 100 clinics in under eight weeks with 95% approvals.
Help us improve and share your feedback! Did you find this helpful?